CLINICAL_TRIALS
trial_result
· 2012-05-03
Clinical Trial Update: Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 study of ITCA 650 (exenatide in the DUROS delivery system) for type 2 diabetes mellitus completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intarcia Therapeutics | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2012-05-03